https://www.huffpost.com/entry/oxford-astrazeneca-coronavirus-vaccine-trial-results_n_5fbfa4d4c5b68ca87f82203d
Save stories to read later or create you own news web site to share with anyone
Notify me when I can create my custom news board
We will not share your email addressAlready on AllSides? Log In
AllSides members can bookmark any article and read it later. Save this article by becoming a member today!
Join AllSides to read, share and understand all perspectives of today's news and issues.
Learn more »AllSides members can instantly post news stories to their own personal page, making it easy to share and discuss information they care about. Become your own publisher by becoming a member today! Learn about My Front Page.
Join AllSides to read, share and understand all perspectives of today's news and issues.
Learn more »
Oxford University and AstraZeneca have acknowledged a manufacturing error meant some trial participants received only a partial dose of their experimental COVID-19 vaccine.
The announcement has raised questions about why researchers did not mention the error when they claimed the jab was “highly effective” just days ago.
It has also raised some concerns about the part of the study which showed a 90% success rate. Oxford and AstraZeneca have since addressed these issues and explained the next steps for the jab, to ensure its safety and effectiveness.
